Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Sci Bull (Beijing) ; 2024 May 22.
Artigo em Inglês | MEDLINE | ID: mdl-38851911

RESUMO

Perovskite light-emitting diodes (PeLEDs) exhibit remarkable potential in the field of displays and solid-state lighting. However, blue PeLEDs, a key element for practical applications, still lag behind their green and red counterparts, due to a combination of strong nonradiative recombination losses and unoptimized device structures. In this report, we propose a buried interface modification strategy to address these challenges by focusing on the bottom-hole transport layer (HTL) of the PeLEDs. On the one hand, a multifunctional molecule, aminoacetic acid hydrochloride (AACl), is introduced to modify the HTL/perovskite interface to regulate the perovskite crystallization. Experimental investigations and theoretical calculations demonstrate that AACl can effectively reduce the nonradiative recombination losses in bulk perovskites by suppressing the growth of low-n perovskite phases and also the losses at the bottom interface by passivating interfacial defects. On the other hand, a self-assembly nanomesh structure is ingeniously developed within the HTLs. This nanomesh structure is meticulously crafted through the blending of poly-(9,9-dioctyl-fluorene-co-N-(4-butyl phenyl) diphenylamine) and poly (n-vinyl carbazole), significantly enhancing the light outcoupling efficiency in PeLEDs. As a result, our blue PeLEDs achieve remarkable external quantum efficiencies, 20.4% at 487 nm and 12.5% at 470 nm, which are among the highest reported values. Our results offer valuable insights and effective methods for achieving high-performance blue PeLEDs.

2.
Sci Bull (Beijing) ; 68(10): 1017-1026, 2023 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-37127489

RESUMO

Metal halide perovskites films have attracted great interest because of their solution-proceed fabrication and potential applications for next-generation displays. However, their non-ideal photoluminescence quantum efficiency (PLQE) and stability still does not meet the requirements of displays. Here, we adopt lanthanum ion (La3+) doping strategy to enhance its luminescence performance and the possibility of taking it to commercialization. In addition to the entry of lanthanum ions into the lattice to greatly improve the crystal quality, the excess La3+ gives rise to the formation of newly developed formamidinium cesium lanthanum bromine, (FA, Cs)2LaBr5, which provides additional energy transport pathways, therefore concentrating more energy onto the perovskite host. Consequently, a near-unity PLQE of 99.5% is realized in standardized green-emission cesium (Cs)/formamidinium (FA) mixed FA0.7Cs0.3PbBr3 perovskite films. The introduction of La3+ can also lead to markedly stability with nearly 1000 days' shelf storage half-lifetime and 400 hours' light-irradiation T90 lifetime as well as much-enhanced color purity. Moreover, the films with La3+ doping enable full-visible spectral enhancement and high-performance white light emission and trichromatic luminescence with 98.9% coverage of the color gamut area required for the Rec. 2020 standard, which suggest that perovskite films have great application potential for backlights in liquid crystal display technologies.


Assuntos
Compostos Inorgânicos , Luminescência , Lantânio , Medicamentos Genéricos , Césio , Excipientes
3.
Adv Mater ; 35(35): e2302161, 2023 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-37168009

RESUMO

Lead halide perovskites have shown exceptional performance in light-emitting devices (PeLEDs), particularly in producing significant electroluminescence in sky-blue to near-infrared wavelengths. However, PeLEDs emitting pure-blue light at 465-475 nm are still not satisfactory. Herein, efficient and stable pure-blue PeLEDs are reported by controlling phase distribution, passivation of defects, as well as surface modifications using multifunctional phenylethylammonium trifluoroacetate (PEATFA) in reduced-dimensional p-F-PEA2 Csn-1 Pbn (Br0.55 Cl0.45 )3n+1 polycrystalline perovskite films. Compared with 4-fluorophenylethylammonium (p-F-PEA+ ) in the pristine films, phenylethylammonium (PEA+ ) has lower adsorption energy while interacting with perovskites, resulting in large-n low-dimensional perovskites, which can greatly facilitate charge transport within the low-dimensional perovskite films. The interaction between the CO group in trifluoroacetate (TFA- ) and perovskites significantly reduces defects in the perovskite films. Additionally, the electron-giving CF3 group in TFA- uplifts surface potential in the films, resulting in smooth electronic injection in devices. The multifunctional additive strategy leads to elevated radiative recombination and efficient carrier transport in the films and devices. As a result, the devices exhibit a maximum external quantum efficiency (EQE) of 11.87% at 468 nm with stable spectral output, the highest reported to date for pure-blue PeLEDs. Thus, this study extends the way for high-efficiency pure-blue LED with perovskite polycrystal films.

4.
Diagnostics (Basel) ; 12(8)2022 Aug 16.
Artigo em Inglês | MEDLINE | ID: mdl-36010330

RESUMO

Parkinson's Disease (PD) is a brain disorder that causes uncontrollable movements. According to estimation, roughly ten million individuals worldwide have had or are developing PD. This disorder can have severe consequences that affect the patient's daily life. Therefore, several previous works have worked on PD detection. Automatic Parkinson's Disease detection in voice recordings can be an innovation compared to other costly methods of ruling out examinations since the nature of this disease is unpredictable and non-curable. Analyzing the collected vocal records will detect essential patterns, and timely recommendations on appropriate treatments will be extremely helpful. This research proposed a machine learning-based approach for classifying healthy people from people with the disease utilizing Grey Wolf Optimization (GWO) for feature selection, along with Light Gradient Boosted Machine (LGBM) to optimize the model performance. The proposed method shows highly competitive results and has the ability to be developed further and implemented in a real-world setting.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA